Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim

Our aim was to compare the efficacy and safety of two recently developed biosimilars of pegfilgrastim, a pegylated form of the recombinant human granulocyte‐colony stimulating factor (G‐CSF) analog filgrastim with those of the reference pegfilgrastim. We retrospectively analyzed data from patients d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Ka‐Won, Lee, Byung‐Hyun, Jeon, Min Ji, Yu, Eun Sang, Kim, Dae Sik, Lee, Se Ryeon, Sung, Hwa Jung, Choi, Chul Won, Park, Yong, Kim, Byung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476830/
https://www.ncbi.nlm.nih.gov/pubmed/32633471
http://dx.doi.org/10.1002/cam4.3261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476830/
https://www.ncbi.nlm.nih.gov/pubmed/32633471
http://dx.doi.org/10.1002/cam4.3261

Ejemplares similares